| Join us for our first Drug Development Immersion course of the new year. Learn the regulatory, commercial, and scientific factors that enable a drug to be successfully brought to market. Our industry expert presents a holistic view of preclinical and clinical development process and explains how strategic decisions made at each stage impacts subsequent stages and ultimately, the success of the approval and launch. | | Date: February 23-24, 2021 | | | Time: 9:00 am-3:30 pm PST | | | Location: Live, online via Zoom | | | Instructor: Joseph H. Quinn | | | Price: $1325 | | | Discount: Fierce readers get a $100 discount if they use coupon code FIERCE100 | |
|
| | | Fluency in essential terminology and acronyms used in clinical development | | In-depth look at the FDA and EMA regulatory process and sponsor interactions | | Criteria for preclinical studies to support first in human clinical trials | | Rationale, special considerations, and study design for both traditional and non-traditional clinical trial phases | | Understanding of the launch process, life cycle management, and post-approval drug safety monitoring |
|
| |
| | | |
Appropriate for those without a science background who need a foundational understanding of the drug development process.
Ideal for anyone who works in finance, law, marketing, human resources, business development, project management, IT, administrative support, supply chain, research development, non-clinical, clinical, quality assurance, regulatory affairs, policy, government relations and manufacturing. Past participants include: | | | Venture capitalists, bankers, analysts, financial managers | | | | Insurance brokers, real estate professionals | | | | Patient advocacy group staff, disease foundation members | | | | Policy makers, lobbyists, attorneys | | | | Consultants, public relations specialists, journalists | | | | University administrators, tech transfer, research institute support staff | |
| |
|
|